RENBP and metabolic dysfunction-associated steatotic liver disease: Compared with the control group, mRNA and protein expression levels of AG and its receptor GHSR-1a in the hypothalamus significantly increased in the NAFLD group (P<0.05–0.01, Figures 3A, 3B, 3C).